Latest Market Positioning News

Fortescue Ltd has crossed the 75% ownership threshold in Red Hawk Mining, prompting an increase in its takeover offer price from A$1.05 to A$1.20 per share ahead of the March 3 closing date.

Neurizon Therapeutics has been granted a pivotal US patent for its lead drug candidate NUZ-001, extending protection until 2039 and enhancing its commercial and clinical positioning in neurodegenerative disease treatment.

Canyon Resources announces Peter Secker as new CEO, signaling a strategic shift as the company advances its Minim Martap bauxite project toward production.

Kelly Partners Group Holdings Limited reported a robust 22.8% revenue increase to $64.9 million in the first half of 2025, underpinned by strategic acquisitions and international expansion, particularly in the US market.

Delorean Corporation has marked a pivotal quarter with the Financial Investment Decision for its SA1 Bioenergy Project and steady progress on the Yarra Valley Water facility, underpinning its transition to infrastructure ownership in Australia's bioenergy sector.

Amcor delivered steady volume and earnings growth in Q2 FY25, reaffirming its full-year guidance while progressing its transformative merger with Berry Global.

Pinnacle Investment Management Group Limited has reported a remarkable 150.5% increase in net profit for the half year ended 31 December 2024, alongside a 16.7% rise in revenues and a healthy interim dividend announcement.

Xref Limited reported a solid 10% revenue increase to $10.9 million in H1 FY2025, even as a proposed acquisition by SEEK was narrowly rejected by shareholders. The company plans to continue its growth trajectory as an independent ASX-listed entity with new product launches on the horizon.

Pro Medicus has inked a $53 million, seven-year contract with BayCare to deploy its Visage 7 cloud-based imaging platform across Florida’s largest healthcare system, marking a major step in its North American expansion.

Antares Metals has identified 49 uranium targets within its Mt Isa North Project, highlighting ten as high-priority for imminent exploration. The findings suggest a promising geological setting akin to established uranium deposits nearby.

Wellnex Life has secured Therapeutic Goods Administration approval for its Liquid Paracetamol plus Caffeine Soft Gel, marking its fourth market authorisation and opening new revenue avenues.

Viridis Mining and Minerals has raised A$3.5 million through a placement to fund critical development milestones for its Colossus Rare Earth Element project, following a major resource upgrade.